Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. The company operates through Skin Care Products and Medical Instruments segments. It offers face creams, lotions, masks, and essences and lotions; and makeup products, including primers, powders, BB creams, and makeup rem… Read more
Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.98 Billion CNY
Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) has total liabilities worth CN¥1.98 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Yunnan Botanee Bio-Technology Group Co Ltd - Total Liabilities Trend (2017–2024)
This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Yunnan Botanee Bio-Technology Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sunward Intelligent Equipment Co Ltd
SHE:002097
|
China | CN¥16.90 Billion |
|
Brookline Bancorp Inc
NASDAQ:BRKL
|
USA | $10.31 Billion |
|
Guangxi Wuzhou Zhongheng Group Co Ltd
SHG:600252
|
China | CN¥3.80 Billion |
|
IRB Infrastructure Developers Limited
NSE:IRB
|
India | ₹339.66 Billion |
|
Shanghai Chinafortune Co Ltd
SHG:600621
|
China | CN¥48.83 Billion |
|
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd A
SHG:600648
|
China | CN¥29.88 Billion |
|
Techwing Inc
KQ:089030
|
Korea | ₩354.48 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down Yunnan Botanee Bio-Technology Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yunnan Botanee Bio-Technology Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2024)
The table below shows the annual total liabilities of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.12 Billion | +41.89% |
| 2023-12-31 | CN¥1.49 Billion | +33.50% |
| 2022-12-31 | CN¥1.12 Billion | +8.02% |
| 2021-12-31 | CN¥1.03 Billion | +158.47% |
| 2020-12-31 | CN¥400.05 Million | +23.92% |
| 2019-12-31 | CN¥322.82 Million | +3.10% |
| 2018-12-31 | CN¥313.11 Million | +30.79% |
| 2017-12-31 | CN¥239.40 Million | -- |